Ebrahim, Adzmier A.

HRN: 23-44-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2023
AMPICILLIN 250MG (VIAL)
07/27/2023
08/03/2023
IV
95mg
Q12
Potential Septic Newborn
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: